Premium
Uterine sarcoma: A retrospective study
Author(s) -
Wen BChen,
Tewfik Ferial A.,
Tewfik Hamed H.,
Long Jeffrey P.,
Anderson Barrie
Publication year - 1987
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.2930340208
Subject(s) - medicine , chemotherapy , sarcoma , radiation therapy , uterine sarcoma , disease , retrospective cohort study , surgery , oncology , pathology
From 1965 to 1982, 86 analyzable patients with uterine sarcoma were treated. Nineteen patients (22%) presented with advanced disease. For the patients with curable diseases (67 patients), the disease‐free survivals with a median follow‐up of 4.5 years are 40% (surgery only), 53% (surgery + chemotherapy), 46% (surgery + radiation ± chemotherapy). The local failure rates are 43%:32%:33%, respectively. There is no statistical significance. The most important prognostic factor is the clinical extent of the tumor. The role of radiation therapy and chemotherapy will be discussed.